Skip to Content

400 SL SL (Gleevec 400 mg)

Generic Name: imatinib

Pill with imprint 400 SL SL is Orange, Elliptical / Oval and has been identified as Gleevec 400 mg. It is supplied by Novartis Pharmaceuticals.

Gleevec is used in the treatment of chronic myelogenous leukemia; acute lymphoblastic leukemia; chronic eosinophilic leukemia; gastrointestinal stromal tumor; dermatofibrosarcoma protuberans (and more), and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Gleevec 400 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for 400 SL SL

Gleevec 400 mg 400 SL SL
Gleevec 400 mg 400 SL SL Front
Gleevec 400 mg 400 SL SL Back
Gleevec 400 mg 400 SL SL


Generic Name:
400 SL SL
400 mg
Elliptical / Oval
Prescription only
Drug Class:
BCR-ABL tyrosine kinase inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Novartis Pharmaceuticals
National Drug Code (NDC):

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.